Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation

Authors :: J.-S. Frenel
A. Lusque
S. Delaloge
J.-M. Ferrero
T. Bachelot
I. Desmoulins
C. Levy
J.-C. Eymard
A. Gonçalves
A. Patsouris
M. A. Mouret Reynier
M. J.-C. Thery
T. Petit
L. Cabel
L. Uwer
M. Debled
M. Chevrot
A. Mailliez
W. Jacot
T. de La Motte Rouge
Source :: British Journal of Cancer. 128:2072-2080
Publication Year :: 2023
Publisher :: Springer Science and Business Media LLC, 2023.

Full Text Access

Tools